INTERCEPT PHARMACEUTICALS INCINTERCEPT PHARMACEUTICALS INCINTERCEPT PHARMACEUTICALS INC

INTERCEPT PHARMACEUTICALS INC

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
−24.39MXN
‪−2.88 B‬MXN
‪5.57 B‬MXN
Beta (1Y)
−0.55

About INTERCEPT PHARMACEUTICALS INC

CEO
Jerome B. Durso
Headquarters
Morristown
Employees (FY)
341
Founded
2002
Intercept Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the research, development, and commercialization of novel therapeutics in treating chronic liver diseases. Its product pipeline includes OCALIVA, which is used for the treatment of biliary cholangitis, nonalcoholic steatohepatitis, sclerosing cholangitis and biliary atresia. The company was founded by Mark E. Pruzanski and Roberto Pellicciari on September 4, 2002 and is headquartered in Morristown, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ICPT is 329.00 MXN — it has decreased by 30.74% in the past 24 hours. Watch INTERCEPT PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange INTERCEPT PHARMACEUTICALS INC stocks are traded under the ticker ICPT.
ICPT reached its all-time high on May 19, 2020 with the price of 2053.30 MXN, and its all-time low was 329.00 MXN and was reached on Oct 12, 2021. View more price dynamics on ICPT chart.
See other stocks reaching their highest and lowest prices.
ICPT stock is 44.38% volatile and has beta coefficient of −0.55. Track INTERCEPT PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is INTERCEPT PHARMACEUTICALS INC there?
Yes, you can track INTERCEPT PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
INTERCEPT PHARMACEUTICALS INC is going to release the next earnings report on Jul 31, 2024. Keep track of upcoming events with our Earnings Calendar.
ICPT net income for the last quarter is ‪−48.11 M‬ MXN, while the quarter before that showed ‪−99.86 M‬ MXN of net income which accounts for 51.83% change. Track more INTERCEPT PHARMACEUTICALS INC financial stats to get the full picture.
No, ICPT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jun 25, 2024, the company has 341.00 employees. See our rating of the largest employees — is INTERCEPT PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INTERCEPT PHARMACEUTICALS INC EBITDA is ‪−955.31 M‬ MXN, and current EBITDA margin is −23.09%. See more stats in INTERCEPT PHARMACEUTICALS INC financial statements.
Like other stocks, ICPT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INTERCEPT PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INTERCEPT PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INTERCEPT PHARMACEUTICALS INC stock shows the strong sell signal. See more of INTERCEPT PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.